RBC Capital Markets Maintains Underperform Rating for 3M, Sees Limited Upside
RBC Capital Markets has maintained its 'Underperform' rating for 3M (MMM), indicating a belief that the company has limited upside potential.
30 stories found
RBC Capital Markets has maintained its 'Underperform' rating for 3M (MMM), indicating a belief that the company has limited upside potential.
RBC Capital Markets has increased its price target for Vertex Pharmaceuticals (VRTX) as it updates its outlook for the biotech sector. This reflects a positive analyst sentiment towards the company.
RBC Capital Markets has adjusted its price targets for several companies, trimming Procter & Gamble's target due to modest growth while lifting Chevron's target as its commodity view improves.
RBC Capital Markets has reduced its price target for UBS while simultaneously adjusting its assumptions regarding the bank's Assets Under Management (AUM).
RBC Capital Markets has reiterated its 'Outperform' rating for Merck (MRK), acknowledging investor concerns regarding a 'modest premium' but maintaining a positive outlook for the pharmaceutical company.
RBC Capital Markets has identified Revolution, Xenon, and Arrowhead as leading candidates for potential takeovers, according to a recent report.
RBC Capital Markets has set a price target of $45 for Kinross Gold (KGC), outlining the conditions required for the stock to reach this valuation.
RBC Capital Markets has lowered the price target for Sweetgreen, Inc. (SG) due to a same-store sales outlook that is trailing behind consensus estimates.
RBC Capital Markets has increased its price objective for The Bank of Nova Scotia (BNS), citing an improving credit outlook for the bank.
Ares Management Corporation to Present at the 2026 RBC Capital Markets Global Financial Institutions Conference The Globe and Mail
RBC Capital Markets has maintained its Outperform rating on Linde plc (LIN), indicating continued confidence in the company's financial performance and stock potential.
RBC Capital Markets has upgraded its rating for Unilever (UL) stock from its previous position to 'Sector Perform'. This change reflects a revised outlook on the consumer goods giant's market performa
RBC Capital Markets has downgraded the ratings for oilfield services companies NOV and Trican Well Services.
RBC Capital Markets has downgraded Ivanhoe Mines' stock rating, citing expectations of materially lower near-term production for the mining company.
RBC Capital Markets has maintained its Outperform rating on Union Pacific (UNP), while also flagging higher Q1 EPS and potential approval risks for the railway company.

Lofty investor expectations for growth and a balanced risk-reward ratio make shares of Starbucks less compelling, according to RBC Capital Markets.
RBC Capital Markets has reiterated its Outperform rating for Nike (NKE), indicating a positive outlook and seeing a clear path to growth for the sportswear giant.
RBC Capital Markets has reduced its price target for Leidos Holdings, Inc. (LDOS) from $230 to $215, citing a service-focused valuation.
RBC Capital Markets has upgraded its rating for pharmaceutical company AbbVie to 'outperform,' citing expectations for durable growth.
RBC Capital Markets has slightly trimmed its price target for ACADIA Pharmaceuticals, citing seasonal biotech headwinds. The firm also cut its price target for Galapagos NV to $28, while maintaining a Sector Perform rating ahead of its Q1 earnings.
RBC Capital Markets has adjusted its outlook for Becton Dickinson (BDX), trimming its estimates despite stable demand in the MedTech sector.
RBC Capital Markets has upgraded its rating for Asana (ASAN) stock, setting a new price target of $7.
RBC Capital Markets has initiated coverage of Sonida Senior Living with a 'Buy-equivalent' rating.
RBC Capital Markets has increased its stock price target for Canadian National (CN) for the year 2027, indicating a positive outlook for the railway company.
RBC Capital Markets has identified weaknesses in the housing market as a significant risk factor for Installed Building Products, Inc. (IBP).
RBC Capital Markets has raised its price target for Broadcom (AVGO), citing bullish commentary regarding the company's financial outlook for fiscal year 2027.
RBC Capital Markets has issued a note indicating that CareTrust REIT, Inc. (CTRE) is well-positioned, even amid increased general and administrative expenses and investment timing considerations.
Ares Management Corporation is scheduled to present at the 2026 RBC Capital Markets Global Financial Institutions Conference, likely to discuss its financial performance and outlook.
RBC Capital Markets has downgraded Imperial Oil, citing that the company's valuation has become 'stretched' following several years of strong stock performance.